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This bulletin presents key findings from the second drug prevalence survey of households in both Ireland and 
Northern Ireland. The survey sampled a representative number of people aged between 15 and 64 during late 
2006 and early 2007. The survey was carried out according to standards set by the European Monitoring Centre 
for Drugs and Drug Addiction (EMCDDA). Data relating to drug prevalence on a lifetime, last year (recent) and 
last month (current) basis for Ireland, Northern Ireland, and the Island of Ireland are presented in this bulletin. 
Statistically significant changes in prevalence rates between 2002/3 and 2006/7 are presented at the end of 
each results section.
Key Findings
■ On the Island of Ireland one in four 
respondents aged 15-64 years (25%) 
reported taking any illegal drugs at  
some point in their life.
■ Among all adults on the Island of Ireland, 
cannabis was the most commonly used 
illegal drug; lifetime use was 23%, last year 
use was 7% and last month use was 3%.
■ Lifetime cannabis use among all  
adults was 22% in Ireland and 25%  
in Northern Ireland; last year cannabis 
use was 6% in Ireland and 7% in 
Northern Ireland; last month use  
was 3% in both jurisdictions.
■ In Ireland, 24% of respondents aged  
15-64 years reported taking any illegal 
drugs in their lifetime. After cannabis 
(22%), the most commonly reported 
drugs ever used were: magic mushrooms 
(6%), ecstasy (5%), cocaine (5%), 
amphetamines (4%), poppers (3%),  
LSD (3%), solvents (2%), crack (0.6%) 
and heroin (0.4%).
■ In Northern Ireland, 28% of respondents 
aged 15-64 years reported taking any 
illegal drugs at some point in their life. 
After cannabis (25%), the most commonly 
used illegal drugs were: poppers (8%), 
ecstasy (8%), magic mushrooms (7%), 
LSD (7%), amphetamines (6%), cocaine 
(5%), solvents (4%), heroin (0.5%) and 
crack (0.4%).
■ Heroin and crack cocaine use were 
reported by less than 1% of the adult 
population in both jurisdictions.
■ In Ireland, a higher proportion of men  
than women reported use of any  
illegal drugs, 29% compared to 19%  
for lifetime use, 10% compared to 5%  
for last year use and 4% compared  
to 1% for last month use.
■ Similarly, in Northern Ireland illegal drug 
use is more common among men than 
women: 34% of men reported lifetime 
use compared to 22% of women;  
14% of men reported last year use 
compared to 5% of women; and 5%  
of men reported last month use of any 
illegal drugs compared to 2% of women.
■ In Ireland, young adults were more  
likely to use any illegal drugs across all  
time periods, lifetime, last year and  
last month. Lifetime use was highest 
among respondents aged 25-34 years 
(34%). Last year and last month use 
was highest for those aged 15-24 years, 
15% and 6% respectively, thereafter  
use declined with age.
■ A similar pattern was evident in Northern 
Ireland for the use of any illegal drugs. 
The lifetime use of respondents aged 
25-34 years was highest (42%) followed 
by use among respondents aged 15-24 
(38%). The prevalence rates for last year 
and last month use of any illegal drugs 
were highest for the youngest age band 
at 19% and 6%, respectively. Use also 
declined with age in Northern Ireland.
Comparisons between  
2002/3 and 2006/7
All findings reported are statistically 
significant at least at the 5% level.
■ In Ireland, lifetime use of any illegal 
drugs among all adults increased 
between 2002/3 and 2006/7 from 
19% to 24%. Increases were observed 
for the lifetime use of the following 
drugs: cannabis (from 17% to 22%) 
cocaine (from 3% to 5%) and magic 
mushrooms (from 4% to 6%).
■ In Northern Ireland, lifetime use of any 
illegal drugs among all adults increased 
between 2002/3 and 2006/7 from 
20% to 28%. Increases were observed 
for the lifetime use of the following 
drugs: cannabis (from 17% to 25%), 
cocaine (from 2% to 5%), magic 
mushrooms (from 4% to 7%), poppers 
(from 6% to 8%), LSD (from 5% to 
7%), ecstasy (from 6% to 8%) and 
amphetamines (from 4% to 6%).
■ Overall, the gender and age differences 
observed in lifetime use of drugs in the 
2002/3 survey were also observed in 
the 2006/7 survey. Men and younger 
age groups generally reported higher 
lifetime prevalence rates for any illegal 
drugs.
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Introduction
The survey was commissioned by the National Advisory 
Committee on Drugs (NACD) in Ireland and the Drug and 
Alcohol Information and Research Unit (DAIRU) within the 
Department of Health, Social Services and Public Safety 
(DHSSPS) in Northern Ireland.
The main focus of the survey was to obtain prevalence rates  
for key illegal drugs, such as cannabis, ecstasy, cocaine and 
heroin, on a lifetime (ever used), last year (recent use),  
and last month (current use) basis. Similar prevalence  
questions were also asked of alcohol, tobacco, and other  
drugs (e.g. tranquillisers); attitudinal and demographic 
information was also sought from respondents.
Methodology
The questionnaire and methodology for this survey were based  
on best practice guidelines drawn up by the EMCDDA. The 
questionnaires were administered through face-to-face interviews 
with respondents aged between 15 and 64 normally resident  
in households in Ireland and Northern Ireland. Thus persons 
outside these age ranges, or who do not normally reside in 
private households, have not been included in this survey. This 
approach is commonly used throughout the EU and because of 
the exclusion of those living in institutions (for example, prisons, 
hostels) this type of prevalence survey is usually known as a 
general population survey.
Fieldwork for the survey was carried out between October  
2006 and May 2007 and the final achieved sample was 6,969 
(4,967 in Ireland and 2,002 in Northern Ireland). The response 
rate for the survey was 65% in Ireland and 62% in Northern 
Ireland. Area based sampling was applied in Ireland. The first 
stage involved stratifying by Health Board1 area in Ireland.  
Within the Health Board strata Electoral Divisions (EDs) were 
selected as areas. In Northern Ireland, the first stage involved 
stratifying by Health and Social Services Board areas and within 
the strata simple random sampling was used. The achieved 
sample was weighted by gender, age, former Health Board  
area in Ireland and Health and Social Services Board area in 
Northern Ireland, to maximise representativeness of the general 
population. The effects of stratification, clustering and weighting 
have been incorporated in the interval estimates (i.e. design 
effect adjusted). Details of the methodology have been 
1 Since January 2005 the Health Boards in Ireland have undergone 
restructuring and are merged under one authority – the Health Service 
Executive. However for the purpose of comparison with 2002/3 data,  
we have continued to weight the data by the former Health Board areas 
as these correspond with the Regional Drug Task Force structures. The 
above reference relates to the Health Board structures detailed in: Drug 
Use in Ireland and Northern Ireland 2002/2003 Drug Prevalence Survey 
– Health Board (Ireland) & Health and Social Services Board (Northern 
Ireland) Results (Revised) Bulletin 2. 
summarised in a paper published on the websites of the NACD  
(http://www.nacd.ie/) and the DHSSPS (http://www.dhsspsni.
gov.uk/) and comprehensive technical reports containing copies 
of the questionnaires used in each jurisdiction will be published 
separately.
The Research Advisory Group (RAG) decided to change from 
using a pen and paper interviewing technique to computer-
assisted personal interviewing (CAPI), where the interviewer 
records responses electronically. This technique has several 
advantages: interviews can be administered more quickly;  
human error is minimised yielding higher-quality data; and data  
input is managed more efficiently, thus cutting costs.2
Please Note:
■ Prevalence rates for “any illegal drugs” refers to the reported 
use of one or more of the following: amphetamines, 
cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic 
mushrooms, poppers or solvents – see table footnotes.
■ Questions relating to Nubain® were asked only in Northern 
Ireland. To maintain comparability of overall illegal drug 
prevalence rates between Ireland and Northern Ireland,  
this drug is not included in the calculation of the prevalence 
rates for “any illegal drugs”. Prevalence rates for Nubain® are 
not reported in this bulletin but will be included in Bulletin 2.
■ There was a change in the measurement of ‘other opiates’  
in Ireland between 2002/3 and 2006/7. In 2002/3 ‘other 
opiates’ included 9 drugs: Opium, Temgesic®, Diconal®,  
Napps, MSTs®, Pethidine, DF118® (Dihydrocodeine), 
Buprenorphine and Morphine. In 2006/7 the category  
‘other opiates’ was extended to be consistent with Northern 
Ireland, it included: Codeine, Kapake, Diffs, Dikes, Peach, 
Fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone 
(Oxycontin®, Oxynorm®), and Buprenorphine (Subutex®). 
The 2006/7 results for this drug category are reported in this 
bulletin but given the changes in measurement, comparative 
analysis between 2002/3 and 2006/7 is not appropriate.
■ The measurement of the combined group of sedatives, 
tranquillisers and anti-depressants was changed between 
2002/3 and 2006/7. In 2002/3 this drugs category  
was measured using one question while in 2006/7 two 
questions were used. Furthermore in 2006/7 a more 
expansive list of drug categories was used (see technical 
report for further details).
■ A new weighting procedure has been applied to the Island  
of Ireland data to improve the quality. Therefore, some minor 
changes in previously published Island of Ireland prevalence 
rates have occurred. Revised prevalence rates for the 2002/3 
Island of Ireland data together with confidence intervals will 
be published on the NACD website.
2 EMCDDA Handbook on Population Surveys.
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As with other European surveys, people over the age of 64  
are excluded from this survey, as they grew up in an era when 
both the use and availability of illegal drugs were very limited. 
Therefore surveys with older people have, to date, shown very 
low rates of use even on a lifetime basis. This situation will 
change over time as the younger population grows older. Hence 
lifetime prevalence rates are likely to increase for a considerable 
period of time. When examining the data and comparing results 
over time, last year use is the best reflection of changes as it 
refers to recent use. Last month use is equally valuable as it 
refers to current use.
Understanding the Results  
in this Bulletin
Results (revised) from the first Drug Prevalence Survey were published 
in Bulletin 1 (2005) and gave lifetime, last year, and last month 
prevalence rates for key drugs for the Island of Ireland, Ireland, 
and Northern Ireland. This bulletin contains the same information 
for 2006/7 and also provides comparison information between 
2002/3 and 2006/7. Results are given for all respondents, and are 
also presented by gender and by age. All prevalence rates presented 
in the accompanying tables are rounded to one decimal place and 
are rounded to whole numbers in the text (except for percentages 
less than 1%). Calculated percentage changes in prevalence rates 
between 2002/3 and 2006/7 are also rounded to one decimal 
place and reported in this format in the text. Where clarity is 
needed figures are reported to one decimal place for example 
when comparing data across jurisdictions.
As in all sample surveys, the greater the sample size the more 
statistically reliable are the results. Some of the differences  
in prevalence rates in the tables will be attributable to natural 
sample variations. Detailed confidence intervals for all of the 
figures contained in this bulletin can be found on the websites  
of the NACD and DHSSPS.
Invalid responses have been excluded from all analyses. Percentages 
may not always sum to 100 due to either the effect of rounding 
or where respondents could give more than one answer.
When the figure 0.0% appears it does not mean that no-one has 
used the drug, rather it means that in this category no respondent 
reported use. The confidence intervals will provide a prevalence 
rate for all categories of drug use.
The Island of Ireland data was derived by combining the two 
datasets from Northern Ireland and Ireland and calculating an 
independent prevalence rate for the entire island.
Statistical significance tests have been carried out on the drug 
prevalence data in this bulletin. These tests are used to establish 
the degree of confidence with which we can infer that observed 
changes in drug prevalence between 2002/3 and 2006/7 are not 
due to sampling error. In this bulletin, a significance level of 5% 
has been specified which means that the likelihood that sampling 
error accounts for the observed changes is less than 5%.
A population drug prevalence survey has limitations. The more 
problematic drug users may be underrepresented due to the 
complicated and problematic nature of their lives. Therefore 
population drug prevalence surveys are not used to estimate  
the prevalence of problem drug use (i.e. heroin or crack use). 
Whilst this survey includes some young people, it needs to be 
supplemented by a school survey of the teenage population 
such as the European School Survey Project on Alcohol and 
Other Drugs (ESPAD) in Ireland or the Young Persons’ Behaviour 
and Attitudes Survey (YPBAS) in Northern Ireland.
What is Prevalence?
The term prevalence refers to the proportion of a 
population who have used a drug over a particular  
time period. In general population surveys, prevalence 
is measured by asking respondents in a representative 
sample drawn from the population to recall their use  
of drugs. The three most widely used recall periods are: 
lifetime (ever used a drug), last year (used a drug in 
the last twelve months), and last month (used a drug 
in the last 30 days). Provided a sample is representative 
of the total population, prevalence information obtained 
from a sample can be used to infer prevalence in the 
population.
Lifetime prevalence refers to the proportion of the 
sample that reported ever having used the named drug 
at the time they were surveyed. A person who records 
lifetime prevalence may – or may not – be currently 
using the drug. Lifetime prevalence should not be 
interpreted as meaning that people have necessarily 
used a drug over a long period of time or that they will 
use the drug in the future.
Last year prevalence refers to the proportion of the 
sample that reported using a named drug in the year 
prior to the survey. For this reason, last year prevalence 
is often referred to as recent use.
Last month prevalence refers to the proportion of the 
sample that reported using a named drug in the 30 day 
period prior to the survey. Last month prevalence is 
often referred to as current use. A proportion of those 
reporting current use may be occasional (or first-time) 
users who happen to have used in the period leading 
up to the survey – it should therefore be appreciated 
that current use is not synonymous with regular use.
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Results – Ireland
Key Findings
■ Of all adults in Ireland nearly one in four people (24%) 
reported using any illegal drugs in their lifetime. Seven 
percent reported using any illegal drugs in the year prior  
to the survey; and 3% reported last month use.
■ Cannabis was the most commonly used illegal drug with 
22% of the adult population having ever used the drug;  
6% reported using cannabis in the year prior to the survey 
and 3% reported current use.
■ Lifetime prevalence of all other illegal drugs was considerably 
lower than cannabis. For example, 6% reported ever using 
magic mushrooms, followed by ecstasy and cocaine3 (each 
5%), amphetamines (4%), poppers and LSD (each 3%), 
while the use of solvents was reported by 2% of the adult 
population, less than 1% reported use of crack (0.6%) and 
heroin (0.4%).
■ The lifetime prevalence rate for any illegal drugs was highest 
among those aged 25-34 years (34%) followed by those 
aged 15-24 years (28%) and those aged 35-44 years (27%).
■ A higher proportion of men than women continue to report 
lifetime, last year and last month use of any illegal drugs.
■ Women and older adults continue to report higher levels  
of use of sedatives and tranquillisers. A similar pattern  
was found for anti-depressants.
Ireland – Lifetime Prevalence 
(see Table 1.1)
Results from the survey indicated that nearly one in four (24%) 
of the population aged 15-64 years in Ireland have used any 
illegal drugs in their lifetime.
Drug Type
Cannabis was the most commonly used illegal drug with  
22% of the population having ever used the drug. After  
cannabis, lifetime prevalence rates for other drugs were 
substantially lower; magic mushrooms (6%); ecstasy and 
cocaine (each 5%); amphetamines (4%); poppers and LSD 
(each 3%); and solvents (2%). Less than one percent had  
ever used crack (0.6%), heroin (0.4%) and methadone (0.3%). 
Lifetime prevalence for other opiates was 6%. Approximately  
one in ten respondents reported lifetime use of sedatives and 
tranquillisers (11%), and anti-depressants (9%).
3 The term ‘cocaine’ is used in place of ‘cocaine powder’ throughout all text 
for ease of reporting.
Age
The highest lifetime prevalence for use of any illegal drugs  
was amongst those aged 25-34 (34%) followed by the  
15-24 (28%) and 35-44 (27%) age groups. Lower use  
was reported among those aged 45-54 (15%) and those  
aged 55-64 (7%). Last year and last month prevalence rates 
were highest among the youngest age band at 15% and 6%, 
respectively and declined with age thereafter.
Lifetime use of different drugs varied with age. For example, the 
lifetime use of solvents and poppers were highest among those 
aged 15-24 while lifetime use of cannabis, ecstasy, cocaine and 
magic mushrooms was highest among the 25-34 age group. 
Lifetime use of other opiates was highest among the 35-44  
age group (8%). The highest prevalence rates for sedatives  
and tranquillisers (21%) and anti-depressants (12%) were  
found among the 55-64 age group.
Gender
Men reported more illegal drug use than women: 29% 
compared to 19% for lifetime use. Cannabis use was higher 
among men (27%) than women (17%). Lifetime use of ecstasy, 
LSD and magic mushrooms were two times higher among men 
than women. Conversely, women were more likely than men  
to report use of sedatives and tranquillisers (13% compared  
to 8%), other opiates (8% compared with 5%) and anti-
depressants (13% compared to 6%).
Ireland – Last Year 
Prevalence (see Table 1.2)
Of the total sample, 7% reported using any illegal drugs in the 
last year.
Drug Type
In the twelve months preceding the 2006/7 survey, cannabis 
was the most commonly used illegal drug with 6% of all  
adults aged 15-64 reporting use. After cannabis, cocaine (2%) 
and ecstasy (1%) were the next most widely used illegal drugs 
in Ireland. Less than one percent of those surveyed had used 
magic mushrooms, poppers, amphetamines and crack in the 
previous year.
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Age
Consistently, older adults were less likely to have used any  
illegal drugs in the last year (3%) compared to young adults 
(12%) in Ireland. Among those aged 15-24 use of any illegal 
drugs was highest (15%). This age group also reported the 
highest last year use of cannabis (13%), cocaine (3%), ecstasy 
(3%), magic mushrooms (2%), poppers (1%) and crack 
(0.4%). The use of LSD (0.5%) and heroin (0.2%) was 
marginally higher among those aged 25-34 while the use  
of amphetamines (0.8%) was the same in both age groups. 
The highest last year prevalence rates for sedatives and 
tranquillisers (7%), anti-depressants (5%) and other opiates 
(3%) were among older adults aged 35-64.
Gender
Overall in the last year, men (10%) reported more use of any 
illegal drugs when compared to women (5%) in Ireland. The 
greatest difference between men and women was in reported 
cannabis use, 9% and 4% respectively. The last year use of 
cocaine and ecstasy was also higher among men (2% each) 
than women (1% each). Conversely, women (6%) were more 
likely than men (4%) to report using sedatives and tranquillisers, 
in the last year. Women (6%) were twice as likely as men (3%) 
to report using anti-depressants. Last year use of other opiates 
was also higher among women (3%) than men (2%).
Ireland – Last Month 
Prevalence (see Table 1.3)
In the month preceding the survey, 3% of the population 
reported using any illegal drugs.
Drug Type
In Ireland, cannabis (3%) was the most commonly used illegal 
drug in the month preceding the survey. After cannabis, the 
most commonly used illegal drugs in the last month were 
cocaine (0.5%), ecstasy (0.3%), amphetamines and poppers 
(each 0.1%). Last month use of anti-depressants was 3%, 
sedatives and tranquillisers was 3%, current use of other opiates 
was 1% and methadone 0.1%.
Age
In Ireland the youngest age group, those aged 15-24 years, 
reported most use of any illegal drugs in the last month (6%). 
Last month use became lower in successive age groups. Last 
month use of cannabis, ecstasy and crack was also highest 
among those aged 15-24 years. Those aged 35-44 differed 
from other age groups in that heroin use was reported (0.1%). 
Methadone use in the last month was reported among those 
aged 25-34 (0.2%) as well as among the 35-44 age groups 
(0.3%). The highest last month prevalence rates for sedatives 
and tranquillisers (7%), anti-depressants (5%) and other opiates 
(1%) were among the 55-64 age group.
Gender
Men were nearly four times more likely to report any illegal drug  
use (4%) than women (1%). This pattern was also evident for 
last month use of cocaine. A higher proportion of women (4%) 
than men (2%) reported last month use of sedatives and 
tranquillisers. Women (4%) were also twice as likely as men 
(2%) to reported use of anti-depressants in the month prior  
to the survey.
Ireland – Results Comparison 
2002/3-2006/7
All findings reported are statistically significant at least at the  
5% level.
Significant Changes – Lifetime Prevalence
In Ireland, lifetime use of any illegal drugs increased from 18.5% 
in 2002/3 to 24% in 2006/7 among all adults (15-64 years). 
There were increases in the use of any illegal drugs among 
young adults aged 15-34 (from 26.0% to 31.4%) and older 
adults aged 35-64 (from 11.8% to 17.6%). There were 
increases in the use of any illegal drugs among both men  
(from 24.0% to 29.4%) and women (from 13.1% to 18.5%).
Among all adults aged 15-64, there were increases in the lifetime 
use of the following drugs in Ireland: cannabis (from 17.4%  
to 21.9%) cocaine (from 2.9% to 5.0%) magic mushrooms 
(from 3.9% to 5.8%) and ecstasy (from 3.7% to 5.4%).
Since the previous survey there was an increase in the lifetime 
use of cannabis among those aged 35-44 years (from 17.3% to 
24.4%). The greatest increases in lifetime use of the following 
drugs were among the 25-34 age group: cocaine (from 4.2% to 
9.2%) ecstasy (from 6.4% to 11.2%) and magic mushrooms 
(from 6.3% to 9.9%).
Since the previous survey, in Ireland increases were found 
among young adults aged 15-34 in lifetime use of cannabis 
(from 24.0% to 28.6%), cocaine (from 4.5% to 7.8%) and 
magic mushrooms (from 5.9% to 8.4%). Among older adults 
(35-64 years) increases were found in lifetime use of cannabis 
(from 11.4% to 16.1%) cocaine (from 1.4% to 2.6%) 
amphetamines (from 1.3% to 2.1%) ecstasy (from 0.7%  
to 2.3%) magic mushrooms (from 2.0% to 3.5%) solvents 
(from 0.2% to 0.8%) and poppers (from 0.7% to 1.4%).
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Since the last survey, there were increases among men  
in lifetime use of cannabis (from 22.4% to 27.0%) cocaine  
(from 4.1% to 6.7%) ecstasy (from 4.9% to 7.2%) and  
magic mushrooms (from 5.7% to 7.7%).
Among women in Ireland, there were increases in the lifetime 
use of any illegal drugs (from 13.1% to 18.5%) cannabis  
(from 12.3% to 16.6%) cocaine (from 1.6% to 3.3%) magic 
mushrooms (from 2.0% to 3.8%) and poppers (from 1.3%  
to 2.4%) since the last survey.
Significant Changes – Last Year Prevalence
Last year use of any illegal drugs increased from 5.6% in 2002/3  
to 7.2% in 2006/7 among all adults aged 15-64 in Ireland.  
The greatest increase occurred among those aged 25-34 (from 
6.6% to 9.2%) and among women (from 3.4% to 4.7%).
Since the previous survey in Ireland, there was an increase in  
the last year use of ecstasy among older adults aged 35-64, 
(from 0.0% to 0.2%).
Significant Changes – Last Month Prevalence
There was a significant, albeit small increase in last month use  
of cocaine (from 0.0% to 0.2%) among women in Ireland since 
the previous survey.
Among older adults aged 35-64, there was an increase in the 
last year use of ecstasy (from 0.0% to 0.1%) since the previous 
survey in Ireland.
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Results – Northern Ireland
Key Findings
■ More than one in four people surveyed (28%) reported 
ever having used any illegal drugs; one in eleven (9%) 
reported using any illegal drugs in the year prior to the 
survey; and less than one in twenty (4%) reported using 
any illegal drugs in the month prior to the survey.
■ Cannabis was the most commonly used illegal drug with  
one in four respondents (25%) reporting ever having used  
it; 7% reported use in the year before the survey and 3%  
in the month before the survey.
■ Lifetime prevalence rates for other illegal drugs were 
considerably lower than for cannabis: poppers and ecstasy 
(each 8%); magic mushrooms and LSD (each 7%); 
amphetamines (6%); cocaine (5%); solvents (4%);  
heroin (0.5%); and crack (0.4%).
■ Use of any illegal drugs generally declined with age. Forty 
percent of young adults aged 15-34 reported ever using any 
illegal drugs whereas the corresponding figure for older 
adults aged 35-64 was 19%.
■ Use of any illegal drugs was more common amongst men 
than women, with 5% of males reporting use in the month 
prior to the survey compared to 2% of females.
■ Women and older age groups showed higher levels of use 
of sedatives and tranquillisers. A similar gender and age 
pattern was also found for anti-depressants.
Northern Ireland – Lifetime 
Prevalence (see Table 2.1)
Results from the survey suggested that more than a quarter 
(28%) of the Northern Ireland adult population aged 15-64 
have ever used any illegal drugs.
Drug Type
Cannabis was by far the most commonly used illegal drug  
with one quarter of respondents (25%) reporting lifetime use. 
Cannabis use was higher among young adults with more than 
one in three (35%) of those aged 15-34 reporting use. Lifetime 
prevalence rates for other illegal drugs were substantially lower: 
poppers and ecstasy (each 8%); magic mushrooms and LSD 
(each 7%); amphetamines (6%); cocaine (5%); and solvents 
(4%). Less than one percent of respondents reported ever  
using heroin (0.5%), crack (0.4%) and methadone (0.1%). 
Approximately one fifth of those surveyed reported lifetime  
use of other drugs: anti-depressants (21%), sedatives and 
tranquillisers (20%) and other opiates (20%).
Age
Overall lifetime prevalence rates for the use of any illegal  
drugs were highest among younger age groups, with two  
in five young adults aged 15-34 (40%) reporting use: there  
was little difference in lifetime prevalence rates between those 
aged 15-24 (38%) and those aged 25-34 (42%). For older  
age groups prevalence rates were lower: 28% for those aged 
35-44 falling to 6% for those aged 55-64.
Lifetime prevalence rates for different drugs varied with age.  
For example, lifetime rates for the use of cannabis, ecstasy, 
poppers, LSD, amphetamines, cocaine, magic mushrooms and 
solvents were highest among those aged 25-34. In contrast, 
respondents aged 45-54 reported the highest lifetime prevalence 
rate for sedatives and tranquillisers. This was also the case for 
anti-depressants. The highest prevalence rate for other opiates 
was among those aged 35-44.
Gender
Male respondents usually reported higher prevalence rates than 
females: 34% of men compared to 22% of women reported 
ever using any illegal drugs.
Cannabis prevalence was higher amongst males (30%) than 
females (19%); other illegal drugs showed an even more 
exclusively male profile, for example, magic mushrooms use was 
reported by 11% of men and 2% of women. Women reported 
higher lifetime prevalence rates than men for anti-depressants 
(28% compared to 13%), other opiates (23% compared to 
17%), and sedatives and tranquillisers (22% compared to 18%).
Northern Ireland – Last Year 
Prevalence (see Table 2.2)
The overall prevalence rate for the use of any illegal drugs  
in the year preceding the survey was 9%.
Drug Type
In the 12 months preceding the survey, cannabis was the  
most commonly used illegal drug with one respondent in 
fourteen (7%) reporting use. After cannabis, the most widely 
used illegal drugs were cocaine, ecstasy (each 2%), poppers 
and amphetamines (each 1%). All other illegal drugs had been 
used by less than one percent of the population surveyed.  
Just under one in ten respondents reported last year use of 
sedatives and tranquillisers (9%), anti-depressants (9%) and 
other opiates (8%).
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Age
The highest last year prevalence rate for many of the illegal  
drugs was amongst those aged 15-24. Of this age group, 19% 
reported using any illegal drugs in the last year with 14% using 
cannabis and 4% using ecstasy. The use of any illegal drugs 
decreased with age: less than one in five young adults aged  
15-34 (17%) reported use in the last year compared to less 
than one in twenty older adults aged 35-64 (4%). However,  
the highest prevalence rates for sedatives and tranquillisers 
(17%) and anti-depressants (16%) were found among those 
aged 45-54.
Gender
Use of any illegal drugs in the last year was considerably more  
prevalent among males (14%) than females (5%). In particular, 
prevalence rates for cannabis, cocaine, ecstasy, poppers, 
amphetamines, solvents and crack were higher amongst men  
– for example, cocaine use amongst males in the last year  
(3%) was three times higher than amongst females (0.9%).  
In contrast, twice the proportion of women (12%) than men 
(6%) reported the use of anti-depressants in the last year.  
The use of other opiates was similar for both men and women 
(8% and 9% respectively).
Northern Ireland –  
Last Month Prevalence  
(see Table 2.3)
Less than one in twenty respondents (4%) reported taking  
any illegal drugs in the month before the survey.
Drug Type
Cannabis was the most commonly used illegal drug, reported  
by 3% of respondents. The next most common illegal drug used 
was ecstasy which was reported by less than one percent 
(0.8%) of respondents. Eight percent of those surveyed used anti-
depressants in the last month, 7% used sedatives and 
tranquillisers and 5% used other opiates.
Age
Younger respondents were more likely than older respondents to 
report using any illegal drugs in the last month. Six percent of 
those aged 15-34 reported taking any illegal drugs in the last 
month compared to 2% of older adults aged 35-64. Of those 
aged 15-24, 4% reported using cannabis in the last month and 
2% reported using ecstasy. The highest last month prevalence 
rates for anti-depressants (14%), sedatives and tranquillisers 
(13%) and other opiates (6%) were found among the 45-54 
age group.
Gender
Men (5%) were more than twice as likely as women (2%) to 
report using any illegal drugs in the last month. Conversely, women 
(11%) were more than twice as likely as men (4%) to report 
using anti-depressants in the last month. Also, a higher proportion 
of women than men (8% compared to 6%) used sedatives and 
tranquillisers.
Northern Ireland – Results 
Comparison 2002/3-2006/7
All findings reported are statistically significant at least at the  
5% level.
Significant Changes – Lifetime Prevalence
Lifetime use of any illegal drugs increased from 20% in 2002/3 
to 28% in 2006/7 among all adults (15-64 years). There were 
increases in lifetime use of any illegal drugs among young adults 
aged 15-34 (from 30.9% to 40.2%) and older adults aged 35-64 
(from 11.5% to 19.3%) as well as among females (from 13.5% 
to 22.1%) and males (from 26.7% to 33.9%). The greatest 
increase in the lifetime use of any illegal drugs (from 8.9%  
to 19.6%) occurred among those aged 45-54.
Among all adults aged 15-64, lifetime use of the following drugs 
increased since the previous survey: cannabis (from 16.8%  
to 24.7%); cocaine (from 1.6% to 5.1%); magic mushrooms 
(from 4.3% to 6.7%); poppers (from 5.5% to 7.8%); LSD  
(from 4.5% to 6.6%); ecstasy (from 5.8% to 7.7%); and 
amphetamines (from 4.0% to 5.8%).
The greatest increases since the previous survey in lifetime  
use of the following drugs were among the 25-34 age group: 
cannabis (from 26.2% to 37.3%), cocaine (from 3.1% to 
10.8%), poppers (from 11.1% to 16.7%), LSD (from 9.5% to 
14.9%), amphetamines (from 8.0% to 12.9%), and ecstasy 
(from 12.4% to 16.9%). However, the greatest increases in 
lifetime use of magic mushrooms (from 5.9% to 11.3%) and 
solvents (from 2.0% to 4.0%) were among those aged 35-44.
Across the age groups, increases since the previous survey  
were found among young adults aged 15-34 in lifetime use  
of cannabis (from 25.1% to 35.0%) and cocaine (from 2.9%  
to 9.1%). Increases among older adults (35-64 years) were 
found in lifetime use of cannabis (from 10.3% to 17.3%), magic 
mushrooms (from 2.7% to 5.6%), LSD (from 1.9% to 4.5%), 
poppers (from 1.3% to 3.4%), amphetamines (from 1.5% to 
3.4%), cocaine (from 0.6% to 2.2%), ecstasy (from 1.4% to 
2.9%), and solvents (from 1.0% to 2.1%).
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Among males, increases since the previous survey were found  
in lifetime use of cannabis (from 23.3% to 30.1%), magic 
mushrooms (from 6.3% to 11.2%), cocaine (from 2.7%  
to 7.3%), and poppers (from 7.3% to 10.9%).
Among females, lifetime use of the following drugs increased 
since the previous survey: cannabis (from 10.5% to 19.3%), 
amphetamines (from 1.8% to 4.4%), cocaine (from 0.5% to 
2.9%), ecstasy (from 3.3% to 5.5%), LSD (from 2.0% to 3.5%), 
heroin (from 0.0% to 0.4%) and crack (from 0.1% to 0.4%).
Significant Changes – Last Year Prevalence
Last year use of any illegal drugs increased from 6.4% in 
2002/3 to 9.4% in 2006/7 among all adults (15-64 years). 
There were increases in last year use of any illegal drugs among 
those aged 15-34 (from 11.7% to 17.3%) and 35-64 (from 
2.2% to 3.7%) as well as among males (from 9.7% to 13.7%) 
and females (from 3.1% to 5.2%). The greatest increase in last 
year use of any illegal drugs (from 8.9% to 15.5%) occurred 
among those aged 25-34.
Among all adults aged 15-64, increases since the previous 
survey, were found in last year use of cannabis (from 5.4% to 
7.2%), cocaine (from 0.5% to 1.9%) and poppers (from 0.5% 
to 1.3%). The greatest increase in last year use of cocaine (from 
0.7% to 5.0%) occurred among the 25-34 age group whereas 
the greatest increases in last year use of cannabis (from 2.2% to 
4.1%) and poppers (from 1.1% to 2.7%) were found among 
females and those aged 15-34 respectively.
Among young adults (15-34 years), there was also an increase 
in last year use of cocaine (from 0.9% to 3.5%) since the 
previous survey. Increases were found among older adults  
(35-64 years) in last year use of cannabis (from 2.0% to 3.3%), 
cocaine (from 0.1% to 0.7%) and LSD (from 0.0% to 0.3%).
Significant Changes – Last Month Prevalence
Across the age groups, there was a decrease since the previous 
survey in last month use of cannabis (from 7.9% to 3.5%) 
among those aged 15-24. Increases were found in last month 
use of cocaine (from 0.1% to 1.2%) among 25-34 year olds 
and amphetamines (from 0.0% to 0.7%) among those in the 
35-44 age group.
Among females, increases since the previous survey were found 
in last month use of any illegal drugs (from 1.1% to 2.4%) and 
ecstasy (from 0.1% to 0.7%).
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Results – Island of Ireland
Key Findings
■ On the Island of Ireland 25% of all adults (15-64 years) 
reported ever having used any illegal drugs; 8% reported 
using any illegal drugs in the year prior to the survey; and 
3% reported using any illegal drugs in the month prior to  
the survey.
■ Cannabis was the most commonly used illegal drug with 
23% of all adults reporting ever having used it; 7% reported 
cannabis use in the year prior to the survey and 3% in the 
month prior to the survey.
■ Lifetime prevalence rates for other illegal drugs on the Island 
of Ireland were considerably lower than for cannabis: ecstasy 
and magic mushrooms (each 6%), cocaine and poppers 
(each 5%), amphetamines and LSD (each 4%) and solvents 
(2%).
■ Lifetime use of any illegal drugs was highest among young 
adults aged 15-34 years (34%) whereas the corresponding 
figure for older adults (aged 35-64) was 18%.
■ Use of any illegal drugs was more common among men 
than women, with 5% of men reporting use in the month 
prior to the survey compared to 2% of females.
■ Higher levels of lifetime use of sedatives and tranquillisers 
were found among women and younger adults. Lifetime use 
of anti-depressants was higher among women and the older 
age groups.
Island of Ireland – Lifetime 
Prevalence (see Table 3.1)
On the Island of Ireland 25% of all adults (15-64 years) 
reported the use of any illegal drugs at some point in their 
lifetime.
Drug Type
Cannabis (23%) was the most commonly used illegal  
drug among all adults in their lifetime. Lifetime use of other 
drugs on the Island of Ireland, in decreasing order were ecstasy  
(6%), magic mushrooms (6%), cocaine (5%), poppers (5%) 
amphetamines (4%), LSD (4%) and solvents (2%). Less than 
one percent reported ever using crack (0.5%), heroin (0.4%) 
and methadone (0.3%). Just over 10% of all adults said they 
had ever used other opiates. Lifetime prevalence rates for 
sedatives and tranquillisers (13%) and anti-depressants (13%) 
were very similar on the Island of Ireland.
Age
Use of any illegal drugs on the Island of Ireland was highest 
among younger age groups with 36% of the 25-34 and  
31% of the 15-24 age groups reporting lifetime use. Among 
older adults, lifetime use of any illegal drugs declined with  
age: 35-44 years (27%), 45-54 years (16%) and 55-64  
years (7%). Cannabis use was most prevalent among the  
two youngest age groups. Lifetime use of the following drugs 
was highest among the 25-34 age group: ecstasy (13%), magic 
mushrooms (11%), cocaine (10%), amphetamines (9%) and 
LSD (8%). Those aged 35-44 years reported the highest lifetime 
use of other opiates (14%) on the Island of Ireland.
Gender
On the Island of Ireland lifetime use of any illegal drugs was 
higher among men (31%) than women (20%).
Cannabis use was higher among men (28%) than women 
(17%). Other illegal drugs showed a similar profile. For example 
ecstasy was reported by 8% of men compared to 4% of 
women, poppers reported by 6% of men and 3% of women 
and cocaine by 7% of men and 3% of women. Lifetime use  
of certain drugs was about three times higher among men than 
women: LSD use was reported by 6% of men and 2% women 
and use of magic mushrooms was reported by 9% men and 
3% of women. On the Island of Ireland more women (12%) 
than men (8%) had ever used other opiates. Lifetime use  
of sedatives and tranquillisers was also higher among women 
(16%) than men (11%) and this pattern was also evident  
for anti-depressants (17% among women compared to 8% 
among men).
Island of Ireland – Last Year 
Prevalence (see Table 3.2)
Results from the survey suggested that 8% of all adults (15-64 
years) had used any illegal drugs in the year prior to the survey.
Drug Type
Nearly 7% of all adults reported using cannabis in the year prior 
to the survey. Of all adults on the Island of Ireland 2% said they 
had used cocaine and 1% had used ecstasy in the last year.  
Less than 1% of respondents had used poppers, amphetamines, 
magic mushrooms and LSD in the last year. Nearly 4% of all 
adults had used other opiates. Nearly 6% reported using 
sedatives and tranquillisers, and anti-depressants in the year  
prior to the survey.
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Age
On the Island of Ireland, last year use of any illegal drugs was 
highest among young adults aged 15-34 years (14%). Lifetime 
rates for the use of cannabis, ecstasy and poppers were highest 
among those aged 15-24.
Young adults (15-34 years) reported slightly lower last year  
use (3%) of other opiates when compared to older adults  
(4%) (35-64 years). However, the highest prevalence rate  
for sedatives and tranquillisers (10%) was among those aged 
55-64 years and the highest prevalence rate for last year use  
of anti-depressants (8%) was among the 45-54 age group.
Gender
For many of the illegal drugs, last year use was reported  
twice as often by men than women on the Island of Ireland: 
cannabis was used by 9% of men and 4% of women;  
cocaine use in the last year was reported by more men (2%) 
than women (1%). Ecstasy use in the last year was also 2% 
among men and 1% among women. Differences between  
men and women also occurred with respect to amphetamines 
and magic mushrooms (0.7% compared to 0.4%). However, 
women reported higher last year prevalence than men for  
other opiates (5% compared to 3%), sedatives and tranquillisers 
(7% compared to 5%) and anti-depressants (8% compared  
to 4%).
Island of Ireland – Last Month 
Prevalence (see Table 3.3)
The overall prevalence rate for the use of any illegal drugs  
in the month preceding the survey was 3%.
Drug Type
In the month preceding the survey cannabis was the most 
commonly used drug with 3% of all adults reporting use. Last 
month prevalence for cocaine use was 0.5%. Very few adults 
reported any last month use of the remaining drugs.
Age
The highest last month prevalence rate was amongst the  
15-24 age group reported the most use of any illegal drugs 
(6%), followed by those aged 25-34 years (4%). The most 
commonly used drugs among young adults (15-34 years) in  
the month prior to the survey were cannabis (4%) and cocaine 
and ecstasy (each 1%). Last month use of other opiates was 
highest among those aged 55-64 years (3%). Respondents 
aged 55-64 also reported the highest lifetime use of sedatives 
and tranquillisers (8%). The 45-54 year age group reported  
the highest last month use of anti-depressants (7%).
Gender
A higher proportion of men (5%) than women (2%) reported 
the use of any illegal drugs in the last month. Last month use 
was higher among men than women for cannabis (4% 
compared to 1%), cocaine (0.7% compared to 0.2%) and 
ecstasy (0.6% compared to 0.3%).
Island of Ireland – Results 
Comparison 2002/3-2006/7
All findings reported are statistically significant at least at the 5% 
level.
Significant Changes – Lifetime Prevalence
On the Island of Ireland, lifetime use of any illegal drugs 
increased from 19.0% in 2002/3 to 25.1% in 2006/7 among 
all adults aged 15-64 years. Since the previous survey, there 
were increases in the use of any illegal drugs among younger 
adults aged 15-34 (from 27.4% to 33.9%) and increases among 
both men (from 24.8% to 30.7%) and women (from 13.2%  
to 19.5%).
Among all adults on the Island of Ireland, there were increases  
in the lifetime use of many illegal drugs since the last survey: 
cannabis (from 17.2% to 22.7%) cocaine (from 2.5% to 5.1%) 
magic mushrooms (from 4.0% to 6.0%) ecstasy (from 4.3%  
to 6.0%) amphetamine (from 3.3% to 4.2%) and poppers 
(from 3.5% to 4.6%).
The largest increases since the last survey in the lifetime use  
of many illegal drugs were reported by those aged 25-34 years: 
cannabis (from 25.5% to 33.4%) cocaine (from 3.7% to 9.6%) 
ecstasy (from 8.2% to 12.8%) magic mushrooms (from 6.7% 
to 10.7%) and amphetamine (from 6.1% to 8.5%).
Examining age differences on the Island of Ireland, there were 
increases in the lifetime use of many drugs among young  
adults aged 15-34: cannabis (from 24.3% to 30.4%) cocaine 
(from 4.1% to 8.2%) ecstasy (from 8.8% to 10.5%) and magic 
mushrooms (from 6.1% to 8.4%). Increases among older adults 
aged 35-64 were found for cannabis (from 11.1% to 16.4%) 
magic mushrooms (from 2.2% to 4.1%), ecstasy (from 0.9%  
to 2.4%) cocaine (from 1.3% to 2.5%) amphetamine (from 
1.3% to 2.5%) LSD (from 1.4% to 2.9%) and poppers (from 
0.9% to 2.0%).
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Since the last survey, increases in the lifetime use of many  
illegal drugs were found among men and women on the Island  
of Ireland: among men there were increases in the lifetime use  
of cannabis (from 22.7% to 27.6%) cocaine (from 3.6% to 
6.9%) magic mushrooms (from 5.9% to 8.7%) and ecstasy 
(from 5.9% to 8.0%). Among women there were increases in 
lifetime use of cannabis (from 11.6% to 17.4%) cocaine (from 
1.3% to 3.2%) ecstasy (from 2.8% to 4.1%) magic mushrooms 
(from 2.1% to 3.4%) amphetamines (from 1.9% to 3.0%) and 
poppers (from 2.0% to 3.1%).
Significant Changes – Last Year Prevalence
Among all adults aged 15-64 last year use of any illegal drugs 
increased from 5.8% in 2002/3 to 7.8% in 2006/7. The 
greatest significant increase was among those aged 25-34  
(from 7.3% to 11.0%). Comparing men and women on the 
Island of Ireland, the increase in last year use of any illegal  
drugs was greater among men (from 8.3% to 10.7%) than 
women (from 3.3% to 4.9%).
Since the last survey there was an increase in the last year  
use of cocaine (from 1.7% to 3.1%) among young adults  
aged 15-34 years.
On the Island of Ireland last year use of cannabis among older 
adults aged 35-64 years increased (from 1.9% to 2.8%) since 
the last survey.
Significant Changes – Last Month Prevalence
On the Island of Ireland, there the changes in last month use  
of illegal drugs were relatively small. The following are the 
statistically significant changes:
There was a small increase in last month use of cocaine among 
those aged 25-34 years (from 0.4% to 1.0%).
Since the last survey changes in the last month use among 
women were found for cocaine (from 0.0% to 0.2%) and 
ecstasy (from 0.1% to 0.3%).
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Table 1.1: Ireland – Lifetime Prevalence (%) 2006/7
Drug
All 
Adults 
15-64 Males Females
Young 
Adults 
15-34
Older 
Adults 
35-64 15-24 25-34 35-44 45-54 55-64
Any illegal drugs* 24.0 29.4 18.5 31.4 17.6 28.5 34.0 26.7 15.0 6.8
Cannabis 21.9 27.0 16.6 28.6 16.1 24.8 31.9 24.4 13.6 6.4
Heroin 0.4 0.5 0.4 0.4 0.4 0.3 0.6 0.7 0.2 0.3
Methadone 0.3 0.3 0.3 0.5 0.2 0.4 0.5 0.5 0.0 0.2
Other Opiates** 6.2 4.7 7.8 4.6 7.6 2.8 6.3 8.3 7.0 7.1
Cocaine (total including crack) 5.3 7.0 3.5 8.2 2.7 7.0 9.3 4.5 2.4 0.3
Crack 0.6 0.8 0.4 1.0 0.2 1.5 0.6 0.4 0.2 0.0
Cocaine Powder 5.0 6.7 3.3 7.8 2.6 6.3 9.2 4.4 2.4 0.3
Amphetamines 3.5 4.6 2.5 5.1 2.1 3.2 6.8 3.4 1.6 0.9
Ecstasy 5.4 7.2 3.6 9.0 2.3 6.5 11.2 4.9 0.7  0.1
LSD 2.9 4.0 1.7 3.6 2.2 1.0 5.9 3.3 1.9 0.9
Magic Mushrooms 5.8 7.7 3.8 8.4 3.5 6.7 9.9 5.8 2.8 0.7
Solvents 1.9 2.3 1.4 3.2 0.8 4.2 2.2 1.6 0.3 0.1
Poppers*** 3.3 4.2 2.4 5.5 1.4 5.9 5.1 2.6 0.9 0.2
Sedatives & Tranquillisers 10.5 8.0 13.2 5.9 14.6 4.8 6.8 10.8 14.6 20.5
Anti-depressants 9.2 5.9 12.5 7.1 11.0 4.8 9.1 10.8 10.1 12.4
Note: All figures are rounded to the nearest decimal place
* For this study, “any illegal drugs” refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
** A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
*** Poppers ie amyl or butyl nitrite.
Table 1.2: Ireland – Last Year Prevalence (%) 2006/7
Drug
All 
Adults 
15-64 Males Females
Young 
Adults 
15-34
Older 
Adults 
35-64 15-24 25-34 35-44 45-54 55-64
Any illegal drugs* 7.2 9.6 4.7 12.1 2.9 15.4 9.2 4.9 2.4 0.3
Cannabis 6.3 8.5 3.9 10.4 2.6 13.1 8.0 4.6 2.0 0.3
Heroin 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.0
Methadone 0.1 0.1 0.2 0.2 0.1 0.0 0.3 0.3 0.0 0.0
Other Opiates** 2.1 1.5 2.8 1.8 2.5 0.9 2.5 2.8 2.2 2.3
Cocaine (total including crack) 1.7 2.3 1.0 3.1 0.5 3.8 2.4 1.0 0.2 0.0
Crack 0.1 0.1 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0
Cocaine Powder 1.6 2.2 0.9 2.9 0.5 3.4 2.4 1.0 0.2 0.0
Amphetamines 0.4 0.5 0.3 0.8 0.1 0.8 0.8 0.2 0.0 0.0
Ecstasy 1.2 1.8 0.6 2.4 0.2 2.8 2.0 0.5 0.0 0.0
LSD 0.2 0.2 0.1 0.4 0.0 0.2 0.5 0.0 0.0 0.0
Magic Mushrooms 0.6 0.9 0.4 1.2 0.2 1.9 0.6 0.3 0.1 0.0
Solvents 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0
Poppers*** 0.5 0.6 0.3 0.9 0.1 1.2 0.7 0.2 0.0 0.0
Sedatives & Tranquillisers 4.7 3.7 5.7 2.6 6.5 1.9 3.2 4.0 7.3 9.3
Anti-depressants 4.3 3.0 5.6 3.2 5.2 2.9 3.5 4.8 5.1 5.9
Note: All figures are rounded to the nearest decimal place
* For this study, “any illegal drugs” refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
** A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
*** Poppers ie amyl or butyl nitrite.
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1.3: Ireland – Last Month Prevalence (%) 2006/7
Drug
All 
Adults 
15-64 Males Females
Young 
Adults 
15-34
Older 
Adults 
35-64 15-24 25-34 35-44 45-54 55-64
Any illegal drugs* 2.9 4.3 1.4 4.8 1.2 6.3 3.5 2.0 1.0 0.2
Cannabis 2.6 4.0 1.1 4.2 1.2 5.3 3.2 1.9 1.0 0.2
Heroin 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0
Methadone 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.3 0.0 0.0
Other Opiates** 1.0 0.9 1.1 0.8 1.1 0.3 1.3 1.0 1.0 1.4
Cocaine (total including crack) 0.5 0.8 0.2 1.0 0.0 1.1 1.0 0.1 0.0 0.0
Crack 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0
Cocaine Powder 0.5 0.7 0.2 1.0 0.0 1.0 1.0 0.1 0.0 0.0
Amphetamines 0.1 0.1 0.1 0.2 0.0 0.2 0.2 0.0 0.0 0.0
Ecstasy 0.3 0.5 0.2 0.6 0.1 1.0 0.2 0.2 0.0 0.0
LSD 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0
Magic Mushrooms 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Poppers*** 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0
Sedatives & Tranquillisers 3.0 2.4 3.5 1.3 4.4 0.8 1.7 2.6 4.8 6.8
Anti-depressants 3.1 2.3 3.9 2.2 3.9 1.5 2.7 3.6 3.7 4.7
Note: All figures are rounded to the nearest decimal place
* For this study, “any illegal drugs” refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
** A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
*** Poppers ie amyl or butyl nitrite.
Table 2.1: Northern Ireland – Lifetime Prevalence (%) 2006/7
Drug
All 
Adults 
15-64 Males Females
Young 
Adults 
15-34
Older 
Adults 
35-64 15-24 25-34 35-44 45-54 55-64
Any illegal drugs* 28.0 33.9 22.1 40.2 19.3 38.4 42.1 28.1 19.6 6.4
Cannabis 24.7 30.1 19.3 35.0 17.3 33.0 37.3 24.7 17.9 6.2
Heroin 0.5 0.6 0.4 0.6 0.4 0.6 0.5 0.2 0.9 0.2
Methadone 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.0 0.0
Other Opiates** 20.2 17.4 23.0 14.4 24.7 8.4 21.1 26.9 23.8 22.6
Cocaine (total including crack) 5.2 7.4 2.9 9.1 2.3 7.7 10.8 4.3 1.4 0.5
Crack 0.4 0.4 0.4 0.6 0.3 0.6 0.5 0.6 0.0 0.0
Cocaine Powder 5.1 7.3 2.9 9.1 2.2 7.7 10.8 4.1 1.4 0.5
Amphetamines 5.8 7.3 4.4 9.1 3.4 5.7 12.9 6.2 2.1 1.2
Ecstasy 7.7 9.9 5.5 14.3 2.9 12.0 16.9 6.2 0.8  0.5
LSD 6.6 9.7 3.5 9.4 4.5 4.6 14.9 7.9 2.9 1.8
Magic mushrooms 6.7 11.2 2.4 8.3 5.6 4.4 12.6 11.3 3.7 0.0
Solvents 3.5 5.1 2.0 5.5 2.1 4.0 7.1 4.0 1.2 0.7
Poppers*** 7.8 10.9 4.9 14.0 3.4 11.6 16.7 6.8 1.7 0.6
Sedatives & Tranquillisers 20.2 18.1 22.3 11.7 26.5 10.1 13.6 22.9 30.5 26.7
Anti-depressants 21.0 13.4 28.4 13.6 26.6 9.8 17.8 26.0 28.8 24.8
Note: All figures are rounded to the nearest decimal place
* For this study, “any illegal drugs” refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
** A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
*** Poppers ie amyl or butyl nitrite.
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Table 2.2: Northern Ireland – Last Year Prevalence (%) 2006/7
Drug
All 
Adults 
15-64 Males Females
Young 
Adults 
15-34
Older 
Adults 
35-64 15-24 25-34 35-44 45-54 55-64
Any illegal drugs* 9.4 13.7 5.2 17.3 3.7 19.0 15.5 5.8 3.1 1.4
Cannabis 7.2 10.3 4.1 12.4 3.3 13.7 11.0 5.5 2.5 1.3
Heroin 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0
Methadone 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other Opiates** 8.4 8.0 8.7 7.1 9.3 4.6 9.9 9.2 9.4 9.4
Cocaine (total including crack) 1.9 2.8 0.9 3.5 0.7 2.3 5.0 1.2 0.5 0.0
Crack 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0
Cocaine Powder 1.9 2.8 0.9 3.5 0.7 2.3 5.0 1.2 0.5 0.0
Amphetamines 1.0 1.1 0.9 1.7 0.4 1.9 1.5 1.2 0.0 0.0
Ecstasy 1.8 2.4 1.2 3.4 0.6 3.7 3.1 0.9 0.2 0.5
LSD 0.2 0.2 0.2 0.0 0.3 0.0 0.0 0.9 0.0 0.0
Magic mushrooms 0.2 0.1 0.3 0.5 0.0 0.6 0.4 0.0 0.0 0.0
Solvents 0.2 0.3 0.1 0.4 0.1 0.3 0.4 0.2 0.0 0.0
Poppers*** 1.3 2.3 0.3 2.7 0.2 3.6 1.7 0.0 0.0 0.6
Sedatives & Tranquillisers 9.2 8.2 10.2 4.6 12.6 3.4 6.0 9.2 16.5 12.8
Anti-depressants 9.1 5.8 12.4 5.8 11.7 4.1 7.7 9.6 16.3 9.0
Note: All figures are rounded to the nearest decimal place
* For this study, “any illegal drugs” refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
** A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
*** Poppers ie amyl or butyl nitrite.
Table 2.3: Northern Ireland – Last Month Prevalence (%) 2006/7
Drug
All 
Adults 
15-64 Males Females
Young 
Adults 
15-34
Older 
Adults 
35-64 15-24 25-34 35-44 45-54 55-64
Any illegal drugs* 3.6 4.9 2.4 5.9 2.0 6.3 5.5 3.0 1.8 0.7
Cannabis 2.6 3.7 1.6 3.7 1.8 3.5 4.0 3.0 1.4 0.7
Heroin 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0
Methadone 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other Opiates** 4.9 5.1 4.7 3.6 5.8 1.7 5.7 5.1 6.4 6.3
Cocaine (total including crack) 0.3 0.7 0.0 0.6 0.2 0.0 1.2 0.0 0.5 0.0
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 0.3 0.7 0.0 0.6 0.2 0.0 1.2 0.0 0.5 0.0
Amphetamines 0.3 0.4 0.2 0.3 0.3 0.3 0.4 0.7 0.0 0.0
Ecstasy 0.8 0.8 0.7 1.4 0.3 2.2 0.5 0.3 0.0 0.5
LSD 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0
Magic mushrooms 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0
Solvents 0.1 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0
Poppers*** 0.3 0.6 0.0 0.7 0.0 0.9 0.6 0.0 0.0 0.0
Sedatives & Tranquillisers 7.1 5.7 8.4 2.3 10.7 1.1 3.6 7.8 13.0 12.0
Anti-depressants 7.5 4.2 10.7 4.2 10.0 1.5 7.1 8.0 13.9 8.2
Note: All figures are rounded to the nearest decimal place
* For this study, “any illegal drugs” refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
** A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
*** Poppers ie amyl or butyl nitrite.
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Table 3.1: Island of Ireland – Lifetime Prevalence (%) 2006/7
Drug
All 
Adults 
15-64 Males Females
Young 
Adults 
15-34
Older 
Adults 
35-64 15-24 25-34 35-44 45-54 55-64
Any illegal drugs* 25.1 30.7 19.5 33.9 18.0 31.3 36.3 27.1 16.3 6.7
Cannabis 22.7 27.9 17.4 30.4 16.4 27.1 33.4 24.5 14.8 6.4
Heroin 0.4 0.5 0.4 0.5 0.4 0.4 0.6 0.5 0.4 0.2
Methadone 0.3 0.3 0.3 0.4 0.2 0.3 0.4 0.4 0.0 0.1
Other Opiates** 10.1 8.3 12.0 7.4 12.4 4.4 10.4 13.6 11.7 11.5
Cocaine (total including crack) 5.2 7.1 3.3 8.5 2.6 7.2 9.7 4.5 2.1 0.3
Crack 0.5 0.7 0.4 0.9 0.2 1.3 0.6 0.5 0.1 0.0
Cocaine Powder 5.1 6.9 3.2 8.2 2.5 6.7 9.6 4.3 2.1 0.3
Amphetamines 4.2 5.3 3.0 6.2 2.5 3.9 8.5 4.2 1.7 1.0
Ecstasy 6.0 8.0 4.1 10.5 2.4 8.1 12.8 5.3 0.8 0.2
LSD 3.9 5.6 2.2 5.3 2.9 2.0 8.4 4.6 2.2 1.2
Magic mushrooms 6.0 8.7 3.4 8.4 4.1 6.1 10.7 7.3 3.0 0.5
Solvents 2.4 3.1 1.6 3.8 1.2 4.2 3.6 2.3 0.5 0.2
Poppers*** 4.6 6.1 3.1 7.9 2.0 7.5 8.4 3.8 1.2 0.3
Sedatives & Tranquillisers 13.2 10.8 15.7 7.5 17.9 6.3 8.7 14.2 19.1 22.2
Anti-depressants 12.5 8.0 17.0 8.9 15.3 6.2 11.5 15.0 15.3 15.8
Note: All figures are rounded to the nearest decimal place
* For this study, “any illegal drugs” refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
** A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
*** Poppers ie amyl or butyl nitrite.
Table 3.2: Island of Ireland – Last Year Prevalence (%) 2006/7
Drug
All 
Adults 
15-64 Males Females
Young 
Adults 
15-34
Older 
Adults 
35-64 15-24 25-34 35-44 45-54 55-64
Any illegal drugs* 7.8 10.7 4.9 13.6 3.1 16.4 11.0 5.2 2.6 0.6
Cannabis 6.5 9.0 4.0 11.0 2.8 13.3 8.8 4.9 2.2 0.6
Heroin 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0
Methadone 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.2 0.0 0.0
Other Opiates** 3.9 3.3 4.5 3.3 4.4 1.9 4.6 4.6 4.2 4.3
Cocaine (total including crack) 1.7 2.5 1.0 3.2 0.5 3.4 3.1 1.0 0.3 0.0
Crack 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0
Cocaine Powder 1.7 2.4 0.9 3.1 0.5 3.1 3.1 1.0 0.3 0.0
Amphetamines 0.6 0.7 0.4 1.0 0.2 1.1 1.0 0.5 0.0 0.0
Ecstasy 1.4 2.0 0.7 2.7 0.3 3.1 2.3 0.6 0.1 0.1
LSD 0.2 0.2 0.1 0.3 0.1 0.2 0.3 0.3 0.0 0.0
Magic mushrooms 0.5 0.7 0.4 1.0 0.1 1.5 0.5 0.2 0.1 0.0
Solvents 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0
Poppers*** 0.7 1.1 0.3 1.4 0.1 1.9 1.0 0.1 0.0 0.2
Sedatives & Tranquillisers 5.9 5.0 6.9 3.1 8.2 2.3 4.0 5.5 9.9 10.3
Anti-depressants 5.6 3.8 7.5 3.9 7.0 3.2 4.7 6.2 8.2 6.8
Note: All figures are rounded to the nearest decimal place
* For this study, “any illegal drugs” refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
** A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
*** Poppers ie amyl or butyl nitrite.
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Table 3.3: Island of Ireland – Last Month Prevalence (%) 2006/7
Drug
All 
Adults 
15-64 Males Females
Young 
Adults 
15-34
Older 
Adults 
35-64 15-24 25-34 35-44 45-54 55-64
Any illegal drugs* 3.1 4.5 1.7 5.1 1.4 6.3 4.1 2.3 1.2 0.3
Cannabis 2.6 3.9 1.3 4.1 1.3 4.8 3.4 2.2 1.1 0.3
Heroin 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0
Methadone 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.0 0.0
Other Opiates** 2.1 2.0 2.1 1.6 2.4 0.7 2.5 2.1 2.5 2.8
Cocaine (total including crack) 0.5 0.8 0.2 0.9 0.1 0.8 1.0 0.1 0.1 0.0
Crack 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0
Cocaine Powder 0.5 0.7 0.2 0.9 0.1 0.7 1.0 0.1 0.1 0.0
Amphetamines 0.2 0.2 0.1 0.2 0.1 0.2 0.2 0.2 0.0 0.0
Ecstasy 0.4 0.6 0.3 0.8 0.1 1.4 0.3 0.2 0.0 0.1
LSD 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0
Poppers*** 0.1 0.3 0.0 0.3 0.0 0.3 0.3 0.1 0.0 0.0
Sedatives & Tranquillisers 4.1 3.3 4.9 1.6 6.2 0.9 2.2 4.0 7.1 8.3
Anti-depressants 4.3 2.8 5.8 2.7 5.6 1.5 4.0 4.8 6.5 5.7
Note: All figures are rounded to the nearest decimal place
* For this study, “any illegal drugs” refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
** A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
*** Poppers ie amyl or butyl nitrite.
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